Journal Home > Volume 2 , Issue 4

Post-stroke neuropsychiatric (NP) disorders are common and have complex etiologies. Multiple factors such as lesion location, personality characteristics, socioeconomic status, pre-stroke psychiatric history, and family support are the determining factors in most cases. Although depression and anxiety are more common, emotional incontinence and catastrophic reactions are also frequently observed. Post-stroke depression (PSD) has been associated with an increased risk of stroke recurrence. Despite its serious consequences and high prevalence, PSD remains undetected and untreated. Treatment options of NP disorders depend on severity, presentation at the time of diagnosis, and patient cooperation, and include antidepressants, mood stabilizers, exercise therapy, psychotherapy, and even revascularization. The efficient management of NP disorders improves outcomes, quality of life, and survival rates in post-stroke patients. However, very few studies have identified definitive treatment for these patients; therefore, further research is required.


menu
Abstract
Full text
Outline
About this article

Management of post-stroke neuropsychiatric disorders

Show Author's information Ahsan Ali Khan1Lukui Chen1( )Guilong Zhang1Xiaoyuan Guo1Guojian Wu1Hong Wang1Yang You1Yuchun Gu2,3Yonggui Yuan4
Department of Neurosurgery, Zhongda Hospital, Southeast University, Nanjing 210009, China
Aston Institute of Regenerative Medicine, Aston Medical School, Aston University, Birmingham, UK
Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing 100871, China
Department of Psychology, Zhongda Hospital, Southeast University, Nanjing 210009, China

Abstract

Post-stroke neuropsychiatric (NP) disorders are common and have complex etiologies. Multiple factors such as lesion location, personality characteristics, socioeconomic status, pre-stroke psychiatric history, and family support are the determining factors in most cases. Although depression and anxiety are more common, emotional incontinence and catastrophic reactions are also frequently observed. Post-stroke depression (PSD) has been associated with an increased risk of stroke recurrence. Despite its serious consequences and high prevalence, PSD remains undetected and untreated. Treatment options of NP disorders depend on severity, presentation at the time of diagnosis, and patient cooperation, and include antidepressants, mood stabilizers, exercise therapy, psychotherapy, and even revascularization. The efficient management of NP disorders improves outcomes, quality of life, and survival rates in post-stroke patients. However, very few studies have identified definitive treatment for these patients; therefore, further research is required.

Keywords: depression, anxiety, post-stroke, neuropsychiatric disorders

References(50)

[1]
de Man-van Ginkel JM, Hafsteinsdóttir TB, Lindeman E, Ettema RGA, Grobbee DE, Schuurmans MJ. In-hospital risk prediction for post-stroke depression: Development and validation of the post-stroke depression prediction scale. Stroke 2013, 44(9): 2441–2445.
[2]
Hosking SG, Marsh NV. Predictors of depression at one year post-stroke in older adults. Brain Impair 2013, 14(3): 381–391.
[3]
Rajashekaran P, Pai K, Thunga R, Unnikrishnan B. Post-stroke depression and lesion location: A hospital based cross-sectional study. Indian J Psychiatry 2013, 55(4): 343–348.
[4]
Zhang WN, Pan YH, Wang XY, Zhao Y. A prospective study of the incidence and correlated factors of post-stroke depression in China. PLoS One 2013, 8(11): e78981.
[5]
Starkstein SE, Lischinsky A. The phenomenology of depression after brain injury. NeuroRehabilitation 2002, 17(2): 105–113.
[6]
Gordon WA, Hibbard MR, Egelko S, Riley E, Simon D, Diller L, Ross ED, Lieberman A. Issues in the diagnosis of post-stroke depression. Rehabil Psychol 1991, 36(2): 71–87.
[7]
Harrington C, Salloway S. The diagnosis and treatment of post-stroke depression. Med Health R I 1997, 80(6): 181–187.
[8]
Robinson RG, Lipsey JR, Price TR. Diagnosis and clinical management of post-stroke depression. Psychosomatics 1985, 26(10): 769–778.
[9]
Gill RK, Cohen DL. 12 month reviews post stroke—Is there a need? Int J Stroke 2013, 8: 33.
[10]
Hall P, Hickey A, Mellon L, Brewer L, Horgan F, Dolan E, Shelley E, McGee H, Kelly P, Williams D. ASPIRE-S: Action on secondary prevention interventions and rehabilitation in stroke—A survey of the adequacy of rehabilitation intervention six months post-stroke. Int J Stroke 2013, 8: 19.
[11]
Burvill PW, Johnson GA, Chakera TMH, Stewart-Wynne EG, Anderson CS, Jamrozik KD. The place of site of lesion in the aetiology of post-stroke depression. Cerebrovasc Dis 1996, 6(4): 208–215.
[12]
Yang SR, Hua P, Shang XY, Hu R, Mo XE, Pan XP. Predictors of early post ischemic stroke apathy and depression: A cross-sectional study. BMC Psychiatry 2013, 13: 164.
[13]
Moore S, Jakovljevic D, Ford GA, Rochester L, Trenell M. The effect of a community exercise intervention on physiological and physical function following stroke: A randomized, controlled trial. Int J Stroke 2012, 7: 76.
[14]
McDonnell MN, Mackintosh SF, Hillier SL, Bryan J. Regular group exercise is associated with improved mood but not quality of life following stroke. PeerJ 2014, 2: e331.
[15]
Boss HM, Van Schaik SM, Deijle IA, de Melker EC, van den Berg BT, Scherder EJ, Bosboom WM, Weinstein HC, Van den Berg-Vos RM. Safety and feasibility of post-stroke care and exercise after minor ischemic stroke or transient ischemic attack: MotiveS & MoveIT. NeuroRehabilitation 2014, 34(3): 401–407.
[16]
Marzolini S, Oh P, McIlroy W, Brooks D. The effects of an aerobic and resistance exercise training program on cognition following stroke. Neurorehabil Neural Repair 2013, 27(5): 392–402.
[17]
Chollet F, Acket B, Raposo N, Albucher JF, Loubinoux I, Pariente J. Use of antidepressant medications to improve outcomes after stroke. Curr Neurol Neurosci Rep 2013, 13: 318.
[18]
Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK, Kaczmarek L, Popa-Wagner A. Post-stroke depression: Mechanisms, translation and therapy. J Cell Mol Med 2012, 16(9): 1961–1969.
[19]
Ramasubbu R. Therapy for prevention of post-stroke depression. Expert Opin Pharmacother 2011, 12(4): 2177–2187.
[20]
Salter KL, McClure JA, Kruger H, Foley NC, Teasell RW. Examining adherence to Canadian best practice recommendations for stroke care: Attitudes, beliefs and barriers to the identification and management of post-stroke depression in current practice. Stroke 2011, 42: E628.
[21]
Wolny T, Saulicz E, Myśliwiec A, Kuszewski M, Kokosz M, Saulicz M, Linek P. Effectiveness of neuromobilisation in upper limb discriminatory sense rehabilitation in late-stage post-stroke patients. Phys Med Rehab Kuror 2014, 24(1): 42–47.
[22]
Hu JF, Chen CJ, Bi XL, Yu ZH, Yang PQ, Fan ZJ, Liu Y, Liu TF. Effect of early intervention of liver-smoothing and blood-activating decoction combined with acupuncture on patients with post-stroke depression. China J Chin Mater Med 2013, 38(14): 2403–2405. (in Chinese)
[23]
He J, Shen PF. Clinical study on the therapeutic effect of acupuncture in the treatment of post-stroke depression. Acupunct Res 2007, 32(1): 58–61. (in Chinese)
[24]
Rasmussen A, Christensen J, Clemmensen PM, Dalsgaard NJ, Dam H, Hindberg I, Lunde M, Plenge P, Mellerup E. Platelet serotonin transporter in stroke patients. Acta Neurol Scand 2003, 107(2): 150–153.
[25]
Golimbet VE, Brusov OS, Factor MI, Zlobina GP, Lezheĭko TV, Lavrushina OM, Petrova EA, Savina MA, Skvortsova VI. Interaction effect of serotonin transporter gene and brain-derived neurotrophic factor on the platelet serotonin content in stroke patients. Zh Nevrol Psikhiatr Im S S Korsakova 2009, 110(4 Suppl 2): 42–45. (in Russian)
[26]
Huang H, Chen K, Guo T, Zhang Y, Qu W, Zhou Z, Liu G, Chen L. Treatment with carotid angioplasty stent placement for post-stroke depression compared to antidepressants. Neurosciences (Riyadh) 2012, 17(1): 53–56.
[27]
Kwakkel G, Winters C, van Wegen EEH, Nijland RHM, van Kuijk AAA, Visser-Meily A, de Groot J, de Vlugt E, Arendzen JH, Geurts ACH, et al. Effects of unilateral upper limb training in two distinct prognostic groups early after stroke: The EXPLICIT-stroke randomized clinical trial. Neurorehabil Neural Repair 2016, 30(9): 804–816.
[28]
Byblow WD, Stinear CM, Barber PA, Petoe MA, Ackerley SJ. Proportional recovery after stroke depends on corticomotor integrity. Ann Neurol 2015, 78(6): 848–859.
[29]
Rao V, Bergey A, Rosenberg P. Sertraline for treatment of post-stroke anxiety. J Neuropsychiatry Clin Neurosci 2012, 24(2): E22.
[30]
Petrova EA, Savina MA, Kontsevoĭ VA, Skvortsova VI. Clinical characteristics of post-stroke anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova 2012, 112(9): 12–16. (in Russian)
[31]
Starkstein SE, Cohen BS, Fedoroff P, Parikh RM, Price TR, Robinson RG. Relationship between anxiety disorders and depressive disorders in patients with cerebrovascular injury. Arch Gen Psychiatry 1990, 47(3): 246–251.
[32]
Devine MJ, Bentley P, Jones B, Hotton G, Greenwood RJ, Jenkins IH, Joyce EM, Malhotra PA. The role of the right inferior frontal gyrus in the pathogenesis of post-stroke psychosis. J Neurol 2014, 261(3): 600–603.
[33]
Prior A, Laursen TM, Larsen KK, Johnsen SP, Christensen J, Andersen G, Vestergaard M. Post-stroke mortality, stroke severity, and preadmission antipsychotic medicine use–A population-based cohort study. PLoS One 2014, 9: e84103.
[34]
Celik Y, Erdogan E, Tuglu C, Utku U. Post-stroke mania in late life due to right temporoparietal infarction. Psychiatry Clin Neurosci 2004, 58(4): 446–447.
[35]
Tatemichi TK, Desmond DW, Stern Y, Paik M, Sano M, Bagiella E. Cognitive impairment after stroke: Frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994, 57(2): 202–207.
[36]
Dong YH, Slavin MJ, Chan BPL, Venketasubramanian N, Sharma VK, Collinson SL, Sachdev PS, Chen CLH. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack. Int Psychogeriatr 2014, 26(5): 787–793.
[37]
Makin SDJ, Turpin S, Dennis MS, Wardlaw JM. Cognitive impairment after lacunar stroke: Systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry 2013, 84: 893–900.
[38]
Schaapsmeerders. Long-term cognitive impairment after first-ever ischemic stroke in young adults. Stroke 2013, 44: E81.
[39]
Tu QY, Ding BR, Yang X, Bai S, Tu JS, Liu X, Wang RR, Tao JH, Jin H, Wang YQ, et al. The current situation on vascular cognitive impairment after ischemic stroke in Changsha. Arch Gerontol Geriatr 2014, 58(2): 236–247.
[40]
Wunderlich MT, Wallesch CW, Goertler M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J Neurol Sci 2004, 227(1): 49–53.
[41]
Brouns R, De Vil B, Cras P, De Surgeloose D, Mariën P, De Deyn PP. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin Chem 2010, 56(3): 451–458.
[42]
Muller U, Murai T, Bauer-Wittmund T, Von Cramon DY. Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Inj 1999, 13(10): 805–811.
[43]
Spalletta G, Bossù P, Ciaramella A, Bria P, Caltagirone C, Robinson RG. The etiology of poststroke depression: A review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006, 11(11): 984–991.
[44]
Schöttke H, Giabbiconi CM. Post-stroke depression and post-stroke anxiety: Prevalence and predictors. Int Psychogeriatr 2015, 27(11): 1805–1812.
[45]
Mnif L, Sellami R, Masmoudi J. Post-stroke emotional incontinence or bipolar disorder? Neuropsychiatr Dis Treat 2016, 12: 1883–1885.
[46]
Douven E, Staals J, Schievink S, Kohler S, van Oostenbrugge RJ, Verhey F, Aalten P. Post-stroke fatigue in patients with post-stroke depression and apathy. Int Psychogeriatr 2015, 27: S159–S159.
[47]
Guiraud V, Gallarda T, Calvet D, Turc G, Oppenheim C, Rouillon F, Mas JL. Depression predictors within six months of ischemic stroke: The DEPRESS study. Int J Stroke 2016, 11(5): 519–525.
[48]
Douven E, Schievink SHJ, Verhey FRJ, van Oostenbrugge RJ, Aalten P, Staals J, Köhler S. The cognition and affect after stroke—A prospective evaluation of risks (CASPER) study: Rationale and design. BMC Neurol 2016, 16: 65.
[49]
Metoki N, Sugawara N, Hagii J, Saito S, Shiroto H, Tomita T, Yasujima M, Okumura K, Yasui-Furukori N. Relationship between the lesion location of acute ischemic stroke and early depressive symptoms in Japanese patients. Ann Gen Psychiatry 2016, 15: 12.
[50]
Fang J, Cheng Q. Etiological mechanisms of post-stroke depression: A review. Neurol Res 2009, 31(9): 904–909.
Publication history
Copyright
Rights and permissions

Publication history

Received: 09 November 2016
Revised: 12 December 2016
Accepted: 14 December 2016
Published: 01 December 2016
Issue date: December 2016

Copyright

© The authors 2016.

Rights and permissions

This article is published with open access at www.TNCjournal.com

Return